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See Article, pages 346–353Psychometric testing has a long tradition in clinical
hepatology. It has been used for decades for the assess-
ment and follow-up of hepatic encephalopathy (HE).
Initially hand-writing, or the construction of a ﬁve-
pointed star were common methods to monitor HE.
But, since the evaluation of these tests could not be
standardized, alternative solutions were sought which
combined convenience, practicability, sensitivity, speci-
ﬁcity, and low costs in terms of money and time.
A ﬁrst approximation towards these goals was the
introduction of the Number Connection Tests into the
assessment of HE [1]. Then comprehensive batteries of
psychometric tests were used, and it was shown that HE
is characterized by a distinct pattern of cognitive impair-
ment: alterations of attention, visuo-spatial perception
and psychomotor function [2–5]. While the verbal IQ
was preserved in patients with overt hepatic encephalop-
athy the performance IQ was found to be decreased even
in patients without clinical signs of HE [2,3].
The PHES – the psychometric hepatic encephalopa-
thy score – has its roots in these ﬂourishing times of neu-
ropsychological assessment of HE. The term PHES was
coined by Dr. Andres Blei in 2001. He suggested to name
the sum score of the PSE-Syndrom-Test [6], a test battery
which had been especially developed for diagnosing HE,
psychometric hepatic encephalopathy score (PHES) [7].
The basis for the PSE-Syndrom-Test had been laid by
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They aimed to characterize the neuropsychological deﬁ-
cit typical for HE, and to develop a short battery that
could be easily used in the clinic to make the diagnosis
of minimal HE. Therefore, they presented a battery of
more than 20 neuropsychological tests to patients with
liver cirrhosis, patients with alcohol-toxic pancreatitis
without liver cirrhosis, patients with alcohol-toxic neu-
ropathy without cirrhosis and healthy controls [8,9].
They found deﬁcits in concentration, attention and
psychomotor function in the liver patients compared to
controls. A discriminant analysis was performed to iden-
tify those variables which were capable of diﬀerentiating
between patients with and without liver cirrhosis and
between patients with HE and patients with alcoholic
brain atrophy and healthy controls. The Digit Symbol
Test, the Benton Test, the Line tracing Test (in particular
the number of errors), reaction time to acoustic and
visual stimuli, and the tests steadiness, aiming and long
sticks from the ‘‘Motorische Leistungsserie”, a battery
aimed to detect alterations of ﬁne motor skills, showed
a high discrimination accuracy. For practicability rea-
sons they decided to develop a paper-pencil-test battery
that represented the aﬀected domains such as visual-
motor coordination, attention shift and motor speed
and accuracy. Considering the results of the discriminant
analysis the Digit Symbol Test (DST), a paper-pencil
version of the Line Tracing Test (LTT) and instead of
aiming the Serial Dotting Test (SDT) were included into
the battery. Then the Number Connection Tests (NCT)
A and B (also referred to as Trailmaking Tests) were
added because these two tests were the most frequently
used psychometric tests for the diagnosis of minimal
HE at that time. The new battery was presented to more
than 400 individuals to develop normative data [10].Published by Elsevier B.V. All rights reserved.
Fig. 1. Examples of the German (a) and Italian (b) versions of the NCT B and of the Figure Connection Test which substitutes the NCT B in the Indian
version of the test battery. The Italian version of the NCT B was provided by Dr. Piero Amodio, Clinical and Experimental Medicine; University of
Padova. The example of the Figure Connection Test (c) was provided by Dr. Radha K. Dhiman, Additional Professor, Department of Hepatology,
Postgraduate Institute of Medical Education & Research, Chandigarh, India.
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ment of Internal Medicine, part were forced to undergo a
neuropsychological examination to keep their driving
licence. Unfortunately, the age pattern of this ‘‘represen-
tative group” was disproportionate. Therefore, in a sec-
ond step the battery was presented to a group of 120
healthy controls with a balanced pattern of age, educa-
tion and occupation [11]. Finally, in 1999, the battery
was published by SWETS Test Services in German.
Hamster and Schomerus made several attempts to
publish their data regarding an optimal test combina-
tion for the diagnosis of HE. At the end of the eighties,
however, psychometric testing – especially the applica-
tion of paper-pencil-tests – had become obsolete. More
‘‘sophisticated” technical methods were expected to pro-
duce a higher sensitivity and a higher speciﬁcity than
paper-pencil-tests [12–14].
Drs. Hamster and Schomerus would be highly
pleased to see their test battery ﬁnally being appreciated
all over the world. After the standardization inFig. 2. Apart from cognitive dysfunction hepatic encephalopathy may also resul
example on the left (a) shows the result of a patient with extreme bradykinesia
errors: 12). The example on the right shows the LTT result of a patient without
45 s, number of errors: 198).Germany similar test batteries have also been standard-
ized in Spain [15] and, now, in Italy [16] and the United
Kingdom [17]. An altered test version has been stan-
dardized in India [18].
All test versions used so far are similar with regard to
their principal structure. All combine a digit symbol test,
a serial dotting test, a line tracing test and number or ﬁg-
ure connection tests. Nevertheless, there are signiﬁcant
diﬀerences in details that make it diﬃcult to compare
the results achieved with the diﬀerent test versions.
Amodio et al. [16], for example, used for their battery
presented in this issue of journal the DST, SDT and
LTT forms of the PSE-Syndrom-Test and added previ-
ously developed forms for the NCT A and B because
of diﬀerences between the Italian and German alphabet
sequences. In addition to the distribution of numbers
and letters the dimension of circles and letters in these
tests were diﬀerent from the German forms. The Indian
group substituted the NCT B with a test where the sub-
jects had to connect ﬁgures belonging to a speciﬁc cate-t in a reduction of motor speed or motor accuracy or even both. The LTT
but preserved accuracy in ﬁne movements (LTT time: 225 s, number of
alterations of cognition or motor speed but extensive asterixis (LTT time:
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non-alphabetized patients [19]. Both alterations of the
test (Fig. 1) have measurable inﬂuence on the test per-
formance. The Indian solution even alters the test struc-
ture as their substitute for the NCT B assesses other
cognitive functions than the NCT B (Table 1).
Besides diﬀerences in the structure, there are also
marked diﬀerences in the evaluation procedure of the
tests. All groups compare the subject’s sub-test results
to norms and score them with +1 to 3 points depend-
ing on their position in the +1 to 3 standard deviation
range from the mean. Then a sum score is calculated
which is referred to as Psychometric Hepatic Encepha-
lopathy Score (PHES). Since all groups use the term
PHES for the sum score of their test variation the diﬀer-
ence between the batteries tends to be forgotten and
PHES results from diﬀerent study groups are compared
without reservations. However, there are several very
important diﬀerences in the calculation of the sum score.
They become most evident considering the scoring of the
line tracing test results. Hamster and Schomerus had
shown in their discriminant analysis that performance
time and number of errors added independently to the
discrimination between patients with liver cirrhosis
and their control groups with the number of errors being
even better than the performance time. Therefore, they
included both, performance time and errors into their
sum score [8]. Amodio et al. [16] argue that LTT perfor-
mance time and errors are signiﬁcantly related. Thus
they measure LTT performance by ‘‘error-weighted
time”. Their argumentation is identical to that of the
authors of the Spanish and British normal data, who
also calculate a combined – though completely diﬀer-
ently calculated – score for performance time and errorsTable 1
Cognitive and motor functions addressed by the diﬀerent components of the PH
Sub-test Assessable functions
Number Connection Test A Psychomotor speed; visual scanning eﬃcien
Number Connection Test B Attention set shifting ability, psychomotor
Figure Connection Test [19] Visual perception, visual search, visual sca
working memory
Digit Symbol Test Associative learning; graphomotor speed, c
Serial Dotting Test Motor speed
Line Tracing Test Motor speed and accuracy
Table 2
Advantages and limitations of the psychometric test batteries that have been stan
Advantages Limitations
 High sensitivity
 High speciﬁcity
 High reliability
 High validity
 Simplicity
 Bedside tests
 Low cost
 Need for representative norm data for
gender and socio-cultural background
 Non-applicability of the NCT B in illit
 Need for the control of practice eﬀects[15,17]. The argumentation is based on the data of
healthy controls. It does not take into account that per-
formance time and errors in the LTT represent diﬀerent
aspects of brain function, which may be altered indepen-
dently by any pathophysiology (Fig. 2). Therefore, neu-
ropsychologists suggest to assess performance speed and
accuracy independently, if possible.
The diﬀerent handling of the LTT results in diﬀer-
ences with regard to the range of the sum score. While
the German version provides a range from +6 to 18
the Italian, Spanish and British versions provide a range
from +5 to 15. Considering all changes of test struc-
ture and evaluation it becomes obvious that the cut-oﬀ
score between normal and pathological results must be
diﬀerent between the diﬀerent test versions, and must
be determined for each of the diﬀerent versions, sepa-
rately. Since the test shall discriminate between normal
brain function and hepatic encephalopathy the cut-oﬀ
score should be determined by comparison of healthy
controls and patients with clinically overt HE. Amodio
et al. [16] give reasons for their cut-oﬀ score of 64
by comparing their psychometric results with the EEG
results as they had not examined patients with clinically
overt HE. This approach is comprehensible. However,
like all other substitute measures EEG is not able to
fully represent HE. Even patients with clinically overt
HE may present with normal EEG [13].
The paper by Amodio et al. [16] underscores the prin-
cipal usefulness of the PSE-Syndrom-Test test battery
for diagnosing minimal HE. However, it also highlights
facts that have to be considered in psychometric testing
principally: the inﬂuence of age, education, occupation
and socio-cultural background and practice eﬀects (see
Table 2).ES – delivering test batteries
cy, sequencing, attention, concentration
speed, visual scanning eﬃciency, sequencing, attention, concentration
nning eﬃciency, psychomotor speed, attention, concentration,
ognitive processing speed, visual perception, working memory
dardized for the assessment of minimal hepatic encephalopathy [6,15–18]
each sample studied considering eﬀects of age, education, occupation,
erate subjects
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in a representative sample from one country cannot be
used for the evaluation of individual data in other coun-
tries without control. Due to alterations in educational
levels and daily living activities from one generation to
the other, neuropsychologists recommend the periodic
re-evaluation of normal data even within a distinct
population.
How come, despite of all these drawbacks, the psy-
chometric hepatic encephalopathy score (PHES) based
on one or the other variation of the original PSE-Syn-
drom-Test is increasingly used for diagnosing minimal
HE, worldwide? The battery is practical and easy to
apply, sensitive and speciﬁc, and cheap. Practice eﬀects
in the range as in the present study by Amodio et al.
[16] have not been observed by other groups [11]. None
of the neuro- or psychophysiological methods used com-
petitively has proven to be of greater use for diagnosing
mHE, so far. This holds especially true also for the most
recently recommended measure – the critical ﬂicker fre-
quency [20]. It is foreseeable that the norm diﬀerences
between the diﬀerent European countries will even out
within the next decade. It appears worthwhile to directly
compare meanwhile the raw data of the diﬀerent repre-
sentative samples of diﬀerent countries, and to see
whether the results would be more comparable after
the deletion of one or the other sub-test, or after identi-
cal handling of the raw data. At best, this combined with
a summarisation of all norm data collected to date
would result in more widely applicable norms, which,
for example, could be used for the assessment of HE
in international multi-centre trials.
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